Active, Not Recruiting
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
NCT07204964
- Conditions
- Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
- Locations
-
- GSK Investigational Site Guntersville, Alabama, United States
- GSK Investigational Site Canoga Park, California, United States
- GSK Investigational Site Walnut Creek, California, United States
- GSK Investigational Site Hialeah, Florida, United States